MARCH 2023
EDITION 23
Clinical Governance Standard
NSLHD CLINICAL AUDIT SCHEDULE
The NSLHD Clinical Audit Schedule has been developed for all sites and services within NSLHD to support the monitoring and evaluation of clinical care processes and to provide support for clinical quality improvement activities across NSLHD. Download the complete 2022-23 NSLHD Clinical Audit Schedule. Note: The Schedule is divided into three categories (NSLHD acute, sub-acute, MHDA and PACH). Visit the clinical audit intranet page for more information. Clinical audits required to be completed this month are listed below.
March 2023 QARS Audits (entry links)
NSLHD_03_Aseptic Technique
St 3
NSLHD_4_Monthly Accountable Drug (S4D_S8) Register Audit (RNSH | HKH | Ryde | MVH | MHDA) NSLHD_05_Cognitive Impairment Audit (Delirium) NSLHD_05_Nutrition Audit NSLHD_05_Surgical plume and electrosurgical audit (RNSH | HKH | Ryde )
St 4
St 5
NSLHD_06_Consent Audit (RNSH | MVH | Ryde | HKH )
St 6
NLSHD_08_Monthly inspection for resuscitation trolley/ Resuscitaire equipment checklists (RNSH | HKH | Ryde | MV | MHDA | PACH-HITH)
St 8
POLICIES, PROCEDURES AND GUIDELINES New, updated and recently published district-wide PPGs. Click on the links below to download documents from the Prompt document system. Refer to the NSLHD weekly bulletin in your inbox to access the most up-to-date list of PPGs Unregistered Babies Less than 20 weeks Gestation Investigation and Bereavement Care (updated) NSLHD Radiation Management Plan (new) NSLHD Radiation Incident Flowchart (new) Nitrous oxide / Entonox therapy for ADULT patients with acute pain - NSLHD (updated) Antiplatelet therapy in patients with Acute Coronary Syndrome (ACS) - NSLHD (updated) Construction, Renovation and Maintenance - Infection Prevention and Control Management Guideline Diabetes Mellitus: Capillary Blood Ketone Monitoring for Adults in the Inpatient Setting - NSLHD Neonatal Abstinence Syndrome (NAS) Assessment and Management – NSLHD
SAFETY ALERTS New, updated and recently published
Safety Alert (SA) - Requires immediate attention and action Safety Notice (SN) - Requires risk assessment at the district level Safety Information (SI) - Ensuring that lessons learned from state-wide, national or international sources are shared actively across NSW health system SN:005/23: Potential for error: look-alike medicines presented in blue medicine bottles - issued 06 March 2023 SA:003/23: Encephalitic Flaviviruses (MVEV, JEV, KUNV) - Update for Clinicians - issued 23 February 2023 SN:004/23: Clinician Alert – Foodborne Botulism - issued 22 February 2023 SI:004/23: Potential for error: look-alike HYDROmorphone and morphine sulfate Medsurge® solution for injection - issued 20 February 2023 SN:003/23: Supply disruption: Rapid Fetal Fibronectin (fFN) 10Q cassettes - issued 14 February 2023
For more information, contact: NSLHD-SafetyAlert@health.nsw.gov.au
Medication Safety Updates including medication shortages are available on the CEC website.
Made with FlippingBook - professional solution for displaying marketing and sales documents online